Dr Lalchandani Labs Ltd vs Prevest Denpro Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Dr Lalchandani Labs Ltd is ₹ 6.96 as of 23 Oct 15:30 . The P/E Ratio of Dr Lalchandani Labs Ltd is 0 as of March 2024 .The P/E Ratio of Prevest Denpro Ltd is 26.3 as of March 2024 . The Market Cap of Dr Lalchandani Labs Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Prevest Denpro Ltd is ₹ 423.77 crore as of March 2024 . The revenue of Dr Lalchandani Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Prevest Denpro Ltd for the Jun '26 is ₹ 20.38 crore as compare to the Mar '26 revenue of ₹ 20.35 crore. This represent the growth of 0.15% The ebitda of Dr Lalchandani Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Prevest Denpro Ltd for the Jun '26 is ₹ 8.08 crore as compare to the Mar '26 ebitda of ₹ 8.32 crore. This represent the decline of -2.88% The net profit of Dr Lalchandani Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Prevest Denpro Ltd changed from ₹ 3.67 crore to ₹ 5.64 crore over 9 quarters. This represents a CAGR of 21.04% The Dividend Payout of Dr Lalchandani Labs Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Prevest Denpro Ltd changed from 7.64 % on March 2023 to 5.6 % on March 2026 . This represents a CAGR of -7.47% over 4 years .

About Dr Lalchandani Labs Ltd

Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories.
Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited on 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017.
The Firm was established by Dr. Arjan Lal Chandani and his son Mr. Mohit Lal Chandani as a Partnership Firm in the name of 'Dr. A Lalchandani Pathology Laboratories' in 2011 and in year 2017, they formed a Company in the name and style M/s Dr Lalchandani Labs Limited and took over the Partnership firm. The Company is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through its integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

About Prevest Denpro Ltd

Prevest Denpro Limited is one of the world's leading dental materials manufacturer, which was incorporated on May 05, 1999, with the Registrar of Companies, Jammu & Kashmir.
The Company is primarily involved in the manufacturing of Dental Preparations. The Company develop, manufacture and market a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile.
The product offerings addresses majority of dentists' clinical needs for consumable dental materials.
The product portfolio covers a wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables.
The products are sold in over 75 countries in the regions of Europe, Asia, South America, Middle East and Africa.

FAQs for the comparison of Dr Lalchandani Labs Ltd and Prevest Denpro Ltd

Which company has a larger market capitalization, Dr Lalchandani Labs Ltd or Prevest Denpro Ltd?

Market cap of Dr Lalchandani Labs Ltd is 6 Cr while Market cap of Prevest Denpro Ltd is 453 Cr

What are the key factors driving the stock performance of Dr Lalchandani Labs Ltd and Prevest Denpro Ltd?

The stock performance of Dr Lalchandani Labs Ltd and Prevest Denpro Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Lalchandani Labs Ltd and Prevest Denpro Ltd?

As of October 25, 2026, the Dr Lalchandani Labs Ltd stock price is INR ₹6.96. On the other hand, Prevest Denpro Ltd stock price is INR ₹377.55.

How do dividend payouts of Dr Lalchandani Labs Ltd and Prevest Denpro Ltd compare?

To compare the dividend payouts of Dr Lalchandani Labs Ltd and Prevest Denpro Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.